by Anna Sauerbier       1) EFNA launch ‘Survey of Young Europeans with Neurological Conditions’ http://www.braincouncil.eu/activities/news/efna-launch-survey-of-young-europeans-with-neurological-conditions/   2) Europe’s pharma companies join with non-profit group in push to measure outcomes of medical treatments https://sciencebusiness.net/healthy-measures/news/europes-pharma-companies-join-non-profit-group-push-measure-outcomes-medical… Continue Reading

History Machado-Joseph disease (MJD) is an autosomal dominant (AD) spinocerebellar ataxia (SCA) initially described in descendants of immigrants from the Portuguese islands of the Azores. It was in 1972 that Kenneth K. Nakano and colleagues described the Machado family, with an AD, late onset, cerebellar ataxia with peripheral neuropathy. All family members were descendants from Guilherme Machado, who had migrated from São Miguel (Azores) to Massachusetts in the late nineteenth or early twentieth centuries.

For April 2018, we have selected: Whelan CD, Altmann A, Botia JA, et al., for the ENIGMA-Epilepsy Working Group. Structural brain abnormalities in the common epilepsies assessed in a worldwide ENIGMA study. Brain 2018;141:391-408. Epilepsy affects 0.6-1.5% of the population worldwide with one-third of patients being resistant to antiepileptic treatment. Nowadays epilepsy is considered a network disorder in which several structural changes are involved.

Slovakia, officially the Slovak Republic, is a country in Central Europe. The total area of the Slovak territory is 49 036 km2 and is mostly mountainous. The population is over 5 million. The capital and largest city is Bratislava. However, the Slovak Republic is a young state (established on January 1st, 1993, by the split of Czechoslovakia), indeed it is an old country with rich historical heritage.

by Prof. Radu Tanasescu   Paper: Maggi et al. ‘Central Vein Sign Differentiates Multiple Sclerosis from Central Nervous System Inflammatory Vasculopathies’. Annals of Neurology. 2018;83:283–294. Outline: This paper shows for the first time that central vein assessment in white matter… Continue Reading

THE EUROPEAN ACADEMY OF NEUROLOGY PRESENTS ‘CHALLENGING THE GLOBAL BURDEN OF BRAIN DISEASE’, A COLLABORATION WITH ITN PRODUCTIONS In a unique communications partnership, European Academy of Neurology (EAN) and ITN Productions are producing a news and current affairs-style programme highlighting… Continue Reading

Epilepsy Center, Neurocenter, Kuopio University Hospital and Faculty of Health Sciences, School of Medicine, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland

This Brain Awareness Week EFNA are launching a Survey of Young Europeans with Neurological Conditions.

On 12-14 April the Dystonia Europe 25th Anniversary Conference and D-DAYs 2018 will take place in Brussels, Belgium. The 3-day event will include a special lunch in the EU Parliament.

You can follow the announcement at: www.thebrainprize.org Four neuroscientists working in the UK, Belgium and Germany have today (6 March) won the world’s most valuable prize for brain research.   The 2018 Brain Prize is awarded to Bart De Strooper (London… Continue Reading

The new CME article March 2018: “EAN and ESO consensus statement and practical guidance for pre-hospital management of stroke” is online now! Please log-in and browse to the LEARN section on the EAN Website and answer the questions! All e-learning… Continue Reading

EAN signs a Memorandum of Understanding with Alzheimer Europe. Alzheimer Europe aims at  providing a voice to people with dementia and their carers, at making dementia a European priority and promote a rights-based approach to dementia. The organisation also supports… Continue Reading

EBC – European Brain Council Brain Awareness Week 2018: Expanding brain research in Europe – Education, Behavior and Brain Development 15 March 2018 – European Parliament, Strasbourg, France Co-hosted by MEPs Anne Sander (France, EPP), Daciana Sârbu (Romania, S&D) and… Continue Reading